Table 2.
Diabetes characteristics before surgery
| BPD-DS (n = 7) |
BPD (n = 5) |
RYGB (n = 4) |
Total (n = 16) |
|
|---|---|---|---|---|
| Mean duration of medical treatment of type 2 diabetes, years (min-max) | 19a (4–40) | 17a (10–25) | 10 (6–18) | 16 (4–40) |
| Treatment modality preoperatively (OAD/insulin), n | 2/5 | 0/5 | 1/4 | 3/13 |
| Mean treatment with insulin, years* (min–max) | 6a (3–12) | 7a (4–11) | 3 (1–6) | 6 (1–12) |
| Mean daily amount of insulin, IU* (min–max) | 108b (75–140) | 96a (30–130) | 58 (35–80) | 92 (30–140) |
| Mean HbA1c, % (min–max) | 9.3a (7.3–12.1) | 8.2a (6.3–10.8) | 7.8 (5.8–10.6) | 8.6 (5.8–12.1) |
n = Number of patients; OAD = oral antidiabetic drugs.
*
Relates to n = 13 patients.
a
n.s. compared to RYGB.
b
p < 0.05 compared to RYGB.